Clinical Trial Update: Efficacy, Safety and Tolerability of Andrographolides Versus Placebo in Patients With Progressive Forms of MS [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update evaluating the efficacy, safety and tolerability of andrographolide versus placebo in progressive forms of multiple sclerosis (Phase 1/Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis

Drugs mentioned

• Andrographolide (andrographolide)

Snippet

Sponsor: Innobioscience SpA | Conditions: Primary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive | Phase 1, Phase 2 | Status: UNKNOWN